Dr. Justin Eli Bekelman, MD

Dr. Bekelman practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Bekelman's NPI, 1912174608, was assigned on May 12, 2008. Dr. Bekelman graduated from Yale University School of Medicine in 2003. Dr. Bekelman holds Pennsylvania license MD434180.

Dr. Bekelman's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Bekelman's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Bekelman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bekelman practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Bekelman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Bekelman's licenses on file in 2 states: Pennsylvania and New Jersey.

CMS data shows 292 Medicare services from Dr. Bekelman across 4 procedure codes in 2024, for 246 Medicare patients. Medicare paid $8,454 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 246 Medicare patients who saw Dr. Bekelman in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bekelman's median patient age at 76, with 0% women.

In 2021, Dr. Bekelman wrote 16 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $378 in total drug cost. In 2020, CMS named 24 claims across 1 drug.

Dr. Bekelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 179 papers to Dr. Bekelman, published from 2010 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Prostatic Neoplasms, Medicare and Proton Therapy. Dr. Bekelman has published most often in Int J Radiat Oncol Biol Phys. Dr. Bekelman's most frequent co-authors are John Paul Christodouleas, MD, Ravi Bharat Parikh, MD and Lawrence Nathan Shulman, MD.

Dmand AI links Dr. Bekelman to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Prostatic Neoplasms and Breast Diseases.

CMS Open Payments shows 21 general payments to Dr. Bekelman from 4 drug and device companies from 2019 to 2023. Consulting fees make up the largest share, 94% of the total. AstraZeneca Pharmaceuticals LP paid the most, $13,216.

Dr. Bekelman graduated from Yale University School of Medicine in 2003.